Back

Prognostic value of non-invasive programmed ventricular stimulation in patients with implantable cardioverter-defibrillator: impact of underlying aetiology.

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Novelties in cardiac pacing Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Associate Professor Piotr Futyma

St. Joseph's Heart Rhythm Center, Rzeszow (Poland)

6 More presentations in this session

Presentation thumbnail
Impairment of quality of life among patients with wearable cardioverter defibrillator therapy (lifevest)
Doctor L. Riesinger (Altoetting, DE)
Abstract
Presentation thumbnail
Prognostic relevance of new onset arrhythmia and ICD shocks in primary prophylactic ICD patients
Doctor T. Kleemann (Ludwigshafen, DE)
Abstract
Presentation thumbnail
Prediction model for shock risk and mortality in ICD patients
Doctor L. Bergau (Goettingen, DE)
Abstract
Presentation thumbnail
A value of periodic intracardiac electrograms used in the remote monitoring systems
Doctor N. Ilov (Astrakhan, RU)
Abstract Slides
Presentation thumbnail
A comprehensive scoping review on transvenous temporary pacing therapy
Mr N. Beurskens (Amsterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Novelties in cardiac pacing

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources